Posterbegehung (PO20) – Sektion Klinische Pneumologie
Fortschritte bei Lungenfibrosen 2020
M Pfeifer
1
Center for Pulmonology, Clinic Donaustauf, University of Regensburg
,
TM Maher
2
National Institute for Health Research Respiratory Biomedical Research Unit, Royal
Brompton and Harefield NHS Foundation Trust; National Heart and Lung Institute, Imperial
College, London, Uk; Fibrosis Research Group, National Heart and Lung Institute, Imperial
College, London, UK
,
S Stowasser
3
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
,
Y Nishioka
4
Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan
,
ES White
5
University of Michigan, Division of Pulmonary & Critical Care Medicine, Ann Arbor,
Michigan, USA
,
V Cottin
6
National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices
Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France
,
I Noth
7
Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville,
Virginia, USA
,
M Selman
8
Instituto Nacional de Enfermedades Respiratorias „ismael Cosio Villegas“, Mexico City,
Mexico
,
KB Rohr
3
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
,
D Wachtlin
9
Boehringer Ingelheim Pharma GmbH & Co. Kg, Ingelheim am Rhein, Germany
,
C Ittrich
10
Boehringer Ingelheim Pharma GmbH & Co. Kg, Biberach an der Riss, Germany
,
C Diefenbach
10
Boehringer Ingelheim Pharma GmbH & Co. Kg, Biberach an der Riss, Germany
,
RG Jenkins
11
National Institute for Health Research Respiratory Biomedical Research Centre, City
Campus, Nottingham University Hospital, Nottingham, UK
› Author Affiliations
